Thermo Fisher seeks grant proposals that leverage NGS

By The Science Advisory Board staff writers

September 29, 2021 -- Thermo Fisher Scientific is accepting new proposals that leverage next-generation sequencing (NGS) for its Oncomine Clinical Research Grant.

The firm aims to fund clinical research programs that leverage NGS in solid tumors and hematology-oncology applications. Recipients receive up to $200,000 in reagents and general funding.

Grant proposals can be submitted until October 25, 2021.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.